Drug Metabolism Reviews

Drug Metabolism Reviews is a quarterly peer-reviewed journal published by Taylor & Francis, covering drug metabolism and disposition. Founded in 1972, it is the only international review journal dedicated exclusively to drug metabolism, with a 2025 impact factor of 4.7, indexed in SCIE.《药物代谢综述》（Drug Metabolism Reviews, 简称 Drug Metab. Rev.）是由 Taylor & Francis 出版的季刊同行评审期刊，涵盖药物代谢与处置。该刊创刊于 1972 年，是唯一专门致力于药物代谢的国际综述期刊，2025 年影响因子为 4.7，被 SCIE 收录。

Scope

The journal's stated aim is to publish comprehensive reviews on all aspects of drug metabolism and disposition, with its official scope covering:刊物官方宗旨为发表药物代谢与处置各方面的综合性综述，官方声明的征稿范围包括：

• Drug metabolism and biotransformation: comprehensive reviews on the biotransformation of drugs and xenobiotics, including phase I and phase II metabolism, and the role of enzymes such as cytochromes P450 and UDP-glucuronosyltransferases.药物代谢与生物转化： 关于药物与外源性物质生物转化的综合性综述，包括 I 期与 II 期代谢，以及细胞色素 P450 与 UDP-葡萄糖醛酸转移酶等酶的作用。
• Pharmacokinetics and drug disposition: reviews on the absorption, distribution, metabolism, and excretion of drugs, including pharmacokinetic modeling and drug-drug interactions.药代动力学与药物处置： 关于药物吸收、分布、代谢与排泄的综述，包括药代动力学建模与药物相互作用。
• Toxicology and reactive metabolites: reviews on the toxicological aspects of drug metabolism, including the formation of reactive metabolites, idiosyncratic drug reactions, and drug-induced organ toxicity.毒理学与反应性代谢物： 关于药物代谢毒理学方面的综述，包括反应性代谢物的形成、特异质药物反应与药物诱导的器官毒性。
• Translational and clinical aspects: reviews on the clinical and translational aspects of drug metabolism, including personalized medicine, pharmacogenomics, and the development of novel therapeutic strategies.转化与临床方面： 关于药物代谢临床与转化方面的综述，包括精准医学、药物基因组学与新治疗策略的开发。
• Article types: the journal publishes comprehensive review articles on all aspects of drug metabolism and disposition.栏目设置： 该刊发表药物代谢与处置各方面的综合性综述文章。

History

• Founding: the journal was established in 1972 as the first review journal dedicated exclusively to drug metabolism and disposition.创刊： 该刊于 1972 年创刊，是首本专门致力于药物代谢与处置的综述期刊。
• Taylor & Francis publication: Drug Metabolism Reviews is published by Taylor & Francis, ensuring high editorial standards and expert contributions in pharmaceutical science.Taylor & Francis 出版： 《药物代谢综述》由 Taylor & Francis 出版，确保药学领域的高编辑标准与专家贡献。
• Exclusive focus: throughout its history, the journal has maintained an exclusive focus on drug metabolism and disposition, making it the definitive review journal in the field.专属聚焦： 在其发展历程中，该刊始终专注于药物代谢与处置，成为该领域的权威综述期刊。
• Publication frequency: the journal publishes quarterly, providing regular comprehensive reviews on advances in drug metabolism research.出版频率： 该刊每季出版，定期提供药物代谢研究进展的综合性综述。

Editors

The journal is led by an editor-in-chief supported by associate editors and an editorial board:该刊由主编领导，副主编与编委会协助工作：

• Editor-in-chief: Grover P. Miller, Professor in the Department of Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, serves as the editor-in-chief.主编： 美国阿肯色州小石城阿肯色医科大学生物化学与分子生物学系教授格罗弗·P·米勒（Grover P. Miller）担任主编。
• Associate editors: the editor-in-chief is supported by associate editors with expertise across major areas of drug metabolism and disposition.副主编： 主编由具有药物代谢与处置主要领域专长的副主编协助。
• Editorial board: the journal has a distinguished international editorial board comprising pharmacologists and pharmaceutical scientists from leading institutions worldwide.编委会： 该刊拥有杰出的国际编委会，成员为来自全球顶尖机构的药理学家与药学科学家。
• Open access option: authors can choose to publish open access in this journal, making their articles freely available to readers upon publication in exchange for an article processing charge.开放获取选项： 作者可选择在该刊发表开放获取文章，使论文发表后即向读者免费开放，并支付文章处理费。